Cowen Upgrades Bristol-Myers (BMY) to Outperform, Downgrades Merck (MRK) to Neutral
Tweet Send to a Friend
In the Major Drug sector this morning, an analyst at Cowen and Company upgraded shares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


